Doesn’t look good for the insulin-bong:
“I think Pfizer will wish they had never gotten into this. I doubt they’ll regain their investment,” says Dr. John Buse, president-elect of the American Diabetes Association, who participated in Exubera’s trials. “There is no advantage to Exubera and there may be a safety risk. I see it as my job to talk people out of (using) it.”
Related posts:
- Desperate Pfizer going with ads to save failing Exubera
- Exubera: Stick a fork in it
- Exubera fallout: Breakup by press release
- Exubera: A total failure
- Pfizer blows Exubera away
- Exubera: "Another blow for the bong"
- Why Exubera failed
KevinMD.com on Facebook
Scrubs
{ 1 comment }
“… insulin-bong”.
Now THAT’s a phrase I would have never guessed would show up on your weblog. Or maybe it’s just the “bong” part.
Comments on this entry are closed.